|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||47.85 - 49.39|
|52 Week Range||30.23 - 55.27|
|Beta (5Y Monthly)||0.41|
|PE Ratio (TTM)||58.21|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Is QIAGEN (QGEN) a great pick from the value investor's perspective right now? Read on to know more.
Merger arbitrage specialist releases 3rd-quarter portfolio
QIAGEN (QGEN) aims to leverage its global reach and position in CDx and HPV testing by collaborating with BioNTech.